Mersana Therapeutics Stock Analysis - Daily Balance Of Power

Delisted . USA . 
Delisted Stock . Mersana Therapeutics
MRSNDelisted Delisted Stock  USD 29.08  0.18  0.62%   
Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session.

Daily Balance Of Power Analysis Today

Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session. The current Daily Balance Of Power for Mersana Therapeutics is 0.1118. This reading indicates consistent price behavior relative to the prior session.
  Previous Daily Balance Of PowerDaily Balance Of PowerTrend
0.11180.1118
VolatilityBacktestInformation Ratio  

Mersana Therapeutics Trading Date Momentum

On May 11 2026 Mersana Therapeutics was traded for 29.08 at the closing time. The top price for the day was 30.39 and the lowest listed price was 28.78 . Trading activity remained within a narrow range during the period. Price movement on May 11, 2026 remained within defined bounds. The trading delta at closing time against the current closing price is -0.62% .
BOP trending toward the high of its range signals sustained buying pressure on Mersana Therapeutics. A decline from positive toward zero suggests weakening demand. Conversely, BOP moving from deeply negative toward zero indicates diminishing selling pressure. Divergence between BOP direction and price direction may signal a pending reversal.
Compare Mersana Therapeutics to competition

Mersana Therapeutics Comparable Listed Equities

These listed companies frame Mersana Therapeutics's former industry context and operating niche. For a delisted instrument, comparable peers are more useful for sector reference than for direct trading signals or return forecasting.

Mersana Therapeutics Market Strength Events

Market strength indicators for Mersana Therapeutics stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Mersana Therapeutics.
Accumulation Distribution0.053
Daily Balance Of Power0.1118
Rate Of Daily Change1.01
Day Median Price29.59
Day Typical Price29.42
Market Facilitation Index1.61
Price Action Indicator-0.42
Period Momentum Indicator0.18
Relative Strength Index77.92

Mersana Therapeutics Risk Indicators

Assessing Mersana Therapeutics' risk indicators is a structured way to evaluate the risk-return trade-off for mersana stock. The level of risk embedded in Mersana Therapeutics' feeds directly into exposure calibration.
Mean Deviation7.16
Semi Deviation2.27
Standard Deviation26.03
Variance677.76
Downside Variance17.13
Semi Variance5.16
Expected Short fall-7.83
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Mersana Therapeutics Short Properties

Short sentiment tied to Mersana Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
Common Stock Shares Outstanding4.9 million
Cash And Short Term Investments134.62 million
Mersana Therapeutics has a market cap of 145.36 million, an operating margin of -67.91% (TTM), current ratio of 3.32. Peer comparison of these metrics adds context that absolute values alone cannot provide. Broader economic conditions can influence Mersana Therapeutics's company valuation - related indicators include signals in population.
Mersana Therapeutics currently shows ROE of -5.05%, market cap of USD 145.36 million. Mersana Therapeutics data presented here supports broader research - the resources below add portfolio-level context. The supplemental views below clarify how Mersana Therapeutics complements or overlaps with existing portfolio holdings. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Related Tools for Mersana Stock

OTC execution conditions for Mersana Therapeutics may differ materially from major exchanges.
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.